US Bancorp
ZLAB icon

US Bancorp’s Zai Lab ZLAB Stock Holding History

US Bancorp’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2K Sell
960
-63
-6% -$1.25K ﹤0.01% 3246
2026
Q1 		$19.2K Sell
1,023
-16,748
-94% -$310K ﹤0.01% 3128
2025
Q4 		$313K Sell
17,771
-6,991
-28% -$164K ﹤0.01% 1797
2025
Q3 		$839K Buy
24,762
+324
+1% +$11.2K ﹤0.01% 1234
2025
Q2 		$855K Buy
24,438
+6,073
+33% +$200K ﹤0.01% 1196
2025
Q1 		$664K Buy
18,365
+12,500
+213% +$385K ﹤0.01% 1312
2024
Q4 		$154K Buy
5,865
+5,534
+1,672% +$154K ﹤0.01% 2171
2024
Q3 		$7.99K Sell
331
-44
-12% -$832 ﹤0.01% 3437
2024
Q2 		$6.5K Buy
+375
New +$6.59K ﹤0.01% 3438
2024
Q1 		– Sell
-332
Closed -$9.07K – 4119
2023
Q4 		$9.07K Buy
332
+181
+120% +$4.78K ﹤0.01% 3337
2023
Q3 		$3.67K Sell
151
-139
-48% -$3.7K ﹤0.01% 3521
2023
Q2 		$8.04K Buy
+290
New +$9.49K ﹤0.01% 3339
2022
Q4 		– Sell
-10
Closed – – 4292
2022
Q3 		$0 Buy
+10
New +$428 ﹤0.01% 4242
2022
Q2 		– Sell
-230
Closed -$10K – 4262
2022
Q1 		$10K Sell
230
-3,230
-93% -$156K ﹤0.01% 3385
2021
Q4 		$217K Buy
3,460
+1,228
+55% +$104K ﹤0.01% 1943
2021
Q3 		$235K Buy
2,232
+50
+2% +$7.18K ﹤0.01% 1895
2021
Q2 		$386K Sell
2,182
-16
-0.7% -$2.57K ﹤0.01% 1682
2021
Q1 		$294K Buy
2,198
+161
+8% +$24.9K ﹤0.01% 1759
2020
Q4 		$276K Buy
2,037
+323
+19% +$32.9K ﹤0.01% 1734
2020
Q3 		$142K Buy
1,714
+905
+112% +$72.7K ﹤0.01% 1919
2020
Q2 		$67K Buy
809
+438
+118% +$29.6K ﹤0.01% 2305
2020
Q1 		$19K Buy
371
+151
+69% +$7.87K ﹤0.01% 2786
2019
Q4 		$9K Buy
220
+82
+59% +$3.03K ﹤0.01% 3149
2019
Q3 		$4K Hold
138
– – ﹤0.01% 3302
2019
Q2 		$5K Hold
138
– – ﹤0.01% 3298
2019
Q1 		$4K Hold
138
– – ﹤0.01% 3308
2018
Q4 		$3K Buy
+138
New +$2.56K ﹤0.01% 3349

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

US Bancorp's ZLAB Position: Q2 2026 in Review

US Bancorp reduced its Zai Lab (ZLAB) stake by 6.2% in Q2 2026, selling an estimated $1.25K and leaving 960 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3246.

US Bancorp first reported a position in ZLAB in Q4 2018 and has held it in 27 quarters since. The position peaked at $855K in Q2 2025. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • US Bancorp held 960 shares of Zai Lab worth $18.2K as of Q2 2026.
  • US Bancorp sold 63 Zai Lab shares in Q2 2026, an estimated $1.25K.
  • Zai Lab made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3246 holding.
  • US Bancorp first reported a position in Zai Lab in Q4 2018 and has held it in 27 quarters since.
  • US Bancorp's Zai Lab position peaked at $855K in Q2 2025.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.